Leukemia Protocol - CLL - E2906

E2906

STUDY SUSPENDED 2/2015

A Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post Remission Therapy, Followed by Decitabine Maintenance vs Observation in Newly Diagnosed Acute Myeloid Leukemia in Older Adults (age 60 & older)